July 16, 2024
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
Pharmaceuticals, Biotechnology and Life Sciences
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly…
MARLBOROUGH, Mass., July 15, 2024 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…
Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis…
Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month. WASHINGTON,…
Live video webcast on Wednesday, July 17th at 12:00 PM ET LA JOLLA, CA, July 15, 2024 (GLOBE NEWSWIRE) —…
Five total abstracts presented at ASPN 2024CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) — Five abstracts featuring SPR Therapeutics’ SPRINT PNS…
Live webcast with Frank Knuettel II, Chief Executive Officer and Chief Financial Officer, on Thursday, July 18th at 12:00 PM…
New Shares under the Retail Entitlement Offer and New Options under the Placement and Entitlement Offer expected to commence normal…
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST…
Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as…